While melanoma rates have leveled off for most of the United States, Black and Latino communities are at a higher risk for the disease.
Category: Cancer
From loss comes hope: Pediatric brain tumor treatment shows promise
Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.
Can Prozac fight brain cancer?
The common antidepressant Prozac melts away glioblastoma tumors in laboratory mice, suggesting possible treatment for the deadly cancer.
Unleashing the immune system to fight brain cancers
Neurosurgeon Michael Lim studies how to unleash the immune system to attack a type of brain cancer called glioblastoma.
How ovarian cancers evade the immune system
A common ovarian cancer evades detection by convincing nearby immune cells to treat it as a developing fetus.
How to beat cancer? Find the genes that help it hide
Stanford Medicine researchers conducted an experiment to find new genes that, when knocked out, boost immune cells' cancer-killing ability.
Blood test predicts chances of lymphoma relapse after therapy
Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.
A better COVID-19 vaccine?
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
Keeping treatment-resistant skin cancer cells in check
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
New findings expand hopes for a stem cell cancer ‘vaccine’
Induced pluripotent stem cells share proteins with some cancers. The cells can be used as a vaccine to prevent pancreatic cancers in mice.
Why many stage 3 colorectal cancer patients skip chemo
As risk factors such as no health insurance and low income accumulate, colorectal cancer patients are less likely to finish chemotherapy.
Molecular clues could signal eye cancer survival odds
Stanford Medicine researchers discover that certain proteins can predict survival for patients with a type of eye cancer.
Evading exhaustion to improve CAR-T cell therapy
'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.
Former patient writes book for kids on stem cell transplants
A cancer survivor treated at Stanford has written a book to help kids facing stem cell transplant understand the procedure and approach it with courage.
Earlier colonoscopies halve subsequent cancer risk
People who have their first colonoscopy between the age of 45 and 49 halve their risk of subsequent colorectal cancers, a Stanford Medicine study has found.
How a Nobel laureate’s life story and encouraging words inspire my scientific journey
Editor's update: Emily Ashkin is featured in a podcast from The Lasker Foundation. My legs were starting to ache from standing by my research poster …